Literature DB >> 16618425

Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease.

Ira J Goldberg1, Henry N Ginsberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16618425     DOI： 10.1053/j.gastro.2006.02.040

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  38 in total

1.  Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.

Authors:  Zhao-Xia Yang; Wei Shen; Hang Sun
Journal:  Hepatol Int       Date:  2010-08-12       Impact factor: 6.047

2.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

Authors:  Elisa Fabbrini; B Selma Mohammed; Faidon Magkos; Kevin M Korenblat; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

Review 3.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 4.  Mitochondrial fatty acid oxidation in obesity.

Authors:  Dolors Serra; Paula Mera; Maria Ida Malandrino; Joan Francesc Mir; Laura Herrero
Journal:  Antioxid Redox Signal       Date:  2012-10-05       Impact factor: 8.401

5.  Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.

Authors:  Fengxia Ge; Shengli Zhou; Chunguang Hu; Harrison Lobdell; Paul D Berk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

Review 6.  Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.

Authors:  Vineeta Sharma; Robert O Ryan; Trudy M Forte
Journal:  Biochim Biophys Acta       Date:  2011-12-22

7.  Chronic ethanol consumption increases cardiomyocyte fatty acid uptake and decreases ventricular contractile function in C57BL/6J mice.

Authors:  Chunguang Hu; Fengxia Ge; Eiichi Hyodo; Kotaro Arai; Shinichi Iwata; Harrison Lobdell; José L Walewski; Shengli Zhou; Robin D Clugston; Hongfeng Jiang; Cynthia P Zizola; Kalyani G Bharadwaj; William S Blaner; Shunichi Homma; P Christian Schulze; Ira J Goldberg; Paul D Berk
Journal:  J Mol Cell Cardiol       Date:  2013-02-16       Impact factor: 5.000

8.  CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice.

Authors:  Fatiha Nassir; Okunade L Adewole; Elizabeth M Brunt; Nada A Abumrad
Journal:  J Lipid Res       Date:  2013-08-20       Impact factor: 5.922

9.  Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization.

Authors:  José L Walewski; Fengxia Ge; Michel Gagner; William B Inabnet; Alfons Pomp; Andrea D Branch; Paul D Berk
Journal:  Obes Surg       Date:  2009-10-29       Impact factor: 4.129

10.  Chemical imaging on liver steatosis using synchrotron infrared and ToF-SIMS microspectroscopies.

Authors:  François Le Naour; Marie-Pierre Bralet; Delphine Debois; Christophe Sandt; Catherine Guettier; Paul Dumas; Alain Brunelle; Olivier Laprévote
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.